Chemed grants Joel L. Wherley 12,686 stock options

For the CEO - Vitas Healthcare, the award's options expire on October 20, 2031.

Rhea-AI Filing Summary

Chemed Corp. (CHE) reported a stock-option award to Joel L. Wherley, identified as CEO - Vitas Healthcare, covering 12,686 shares on October 20, 2026. The options have an exercise price of $512.64 per share and vest in three equal annual installments beginning October 20, 2027. Wherley's reported resulting option position was 42,906 underlying shares.

Insider Trade Summary

Grant/Award: 12,686 shares

Grant/Award 1 txn

Insider Wherley Joel L

Role CEO - Vitas Healthcare

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy with tandem tax withholding) F1	12,686	$512.64	$6.50M

Holdings After Transaction: Stock Option (right to buy with tandem tax withholding) — 42,906 contracts (Direct)

Footnotes (1)

1. F1. Vesting in three equal annual installments commencing 10/20/2027

Key Figures

Stock-option award: 12,686 shares Exercise price: $512.64 per share Reported resulting option position: 42,906 underlying shares +2 more

5 metrics

Stock-option award 12,686 shares Awarded October 20, 2026

Exercise price $512.64 per share Stock-option award

Reported resulting option position 42,906 underlying shares After the October 20, 2026 award

Vesting schedule 3 equal annual installments Beginning October 20, 2027

Expiration date October 20, 2031 Stock options

Key Terms

Stock Option, tandem tax withholding, vesting

3 terms

Stock Option financial

"Stock Option (right to buy with tandem tax withholding)"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

tandem tax withholding financial

"right to buy with tandem tax withholding"

vesting financial

"Vesting in three equal annual installments"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did Chemed (CHE) CEO Joel L. Wherley receive?

Joel L. Wherley received an award covering 12,686 shares on October 20, 2026, with an exercise price of $512.64 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/22/2026 - 01:34 PM EDT Accepted by SEC EDGAR 10/22/2026 - 01:34 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wherley Joel L

(Last) (First) (Middle)

255 EAST FIFTH STREET

SUITE 2600

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO - Vitas Healthcare

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy with tandem tax withholding)	$512.64	10/20/2026		A		12,686		(1)	10/20/2031	Capital Stock	12,686	$512.64	42,906	D

Explanation of Responses:

1. Vesting in three equal annual installments commencing 10/20/2027

	Joel L. Wherley	10/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)